Atopic dermatitis: An update

Journal of the American Academy of Dermatology

Volumn 35, Issue 1, 1996, Pages 1-13

  Rothe, Marti Jill ^a   Grant Kels, Jane M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD ALLERGEN; HOUSE DUST ALLERGEN;

ATOPIC DERMATITIS; CLINICAL FEATURE; DERMATOPHAGOIDES PTERONYSSINUS; DIAGNOSTIC APPROACH ROUTE; GENETIC SUSCEPTIBILITY; HISTAMINE RELEASE; HUMAN; IMMUNOMODULATION; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW;

EID: 0029900990     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90486-7     Document Type: Review

References (123)

1. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980; 92:44-7.
2. Kanwar AJ, Dhar S, Kaur S. Evaluation of minor clinical features of atopic dermatitis. Pediatr Dermatol 1991; 8:114-6.
3. Tada J, Toi Y, Akyama H, et al. Infra-auricular fissures in atopic dermatitis. Acta Derm Venereol (Stockh) 1994; 74:129-31.
4. Rudzki E, Samochocki Z, Rebandel P, et al. Frequency and significance of the major and minor features of Hanifin and Rajka among patients with atopic dermatitis. Dermatology 1994;189:41-6.
5. Williams HC, Pembroke AC. Infraorbital crease, ethnic group, and atopic dermatitis. Arch Dermatol 1996; 132:51-4.
6. Diepgen TL, Fartasch M. Recent epidemiological and genetic studies in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1992;176:13-8.
7. Williams HC, Burney PGJ, Pembroke AC, et al. The U.K. Working Party's diagnostic criteria for atopic dermatitis: III. independent hospital validation. Br J Dermatol 1993; 131:406-16.
8. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993;186:23-31.
9. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993;28:719-23.
10. Aberg N, Hesselmar, Aberg B, et al. Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991. Clin Exp Allergy 1995;25:815-9.
11. Dotterud LK, Kvammen B, Lund E, et al. Prevalence and some clinical aspects of atopic dermatitis in the community of Sor-Varanger. Acta Derm Venereol (Stockh) 1995; 75:50-3.
12. Dotterud LK, Kvammen B, Bolle R, et al. A survey of atopic diseases among school children in Sor-Varanger community. Acta Derm Venereol (Stockh) 1994; 74:124-8.
13. Williams HC. Is the prevalence of atopic dermatitis increasing? Clin Exp Dermatol 1992;17:385-91.
14. Williams HC. On the definition and epidemiology of atopic dermatitis. Dermatol Clin 1995;13:649-57.
15. Kay J, Gawkrodger DJ, Mortimer MJ, et al. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 1994;30:35-9.
16. Poysa L, Korppi M, Pietikainen M, et al. Asthma, allergic rhinitis and atopic eczema in Finnish children and adolescents. Allergy 1991;46:161-5.
17. Varjonen E, Kalimo K, Lammintausta K, et al. Prevalence of atopic disorders among adolescents in Turku, Finland. Allergy 1992;47:243-8.
18. Sladden MJ, Dure-Smith B, Berth-Jones J, et al. Ethnic differences in the pattern of skin disease seen in a dermatology department - atopic dermatitis is more common among Asian referrals in Leicestershire. Clin Exp Dermatol 1991;16:348-9.
19. Jaafar RB, Pettit JHS. Atopic eczema in a multiracial country (Malaysia). Clin Exp Dermatol 1993;18:496-9.
20. Neame RL, Berth-Jones J, Kurinczuk JJ, et al. Prevalence of atopic dermatitis in Leicester: a study of methodology and examination of possible ethnic variation. Br J Dermatol 1995;132:772-7.
21. Williams HC, Pembroke AC, Forsdyke H, et al. London-born black Caribbean children are at increased risk of atopic dermatitis. J Am Acad Dermatol 1995;32:212-7.
22. Williams HC, Strachan DP, Hay RJ. Childhood eczema: disease of the advantaged. Br Med J 1994;308:1132-5.
23. Cookson WOCM, Sharp PA, Faux JA, et al. Linkage between immunoglobulin E responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989;1:1292-5.
24. Young RP, Sharp PA, Lynch JR, et al. Confirmation of genetic linkage between atopic IgE responses and chromosome 11q13. J Med Genet 1992;29:236-8.
25. Coleman R, Trembath RC, Harper JI. Chromosome 11q13 and atopy underlying atopic eczema. Lancet 1993; 341:1121-2.
26. Uehara M, Kimura C. Descendant family history of atopic dermatitis. Acta Derm Venereol (Stockh) 1993;73:62-3.
27. Dold S, Wjst M, von Mutius E, et al. Genetic risk for asthma, allergic rhinitis, and atopic dermatitis. Arch Dis Child 1992;67:1018-22.
28. Cookson WOCM, Young RP, Sandford AJ, et al. Maternal inheritance of atopic IgE responsiveness on chromosome 11q. Lancet 1992;340:381-4.
29. Sampson HA. Food hypersensitivity and dietary management in atopic dermatitis. Pediatr Dermatol 1992; 9:376-9.
30. Bos JD, Kapsenberg ML, Sillevis Smit JH. Pathogenesis of atopic eczema. Lancet 1994;343:1338-41.
31. Morren M-A, Przybilla B, Bamelis M, et al. Atopic dermatitis: triggering factors. J Am Acad Dermatol 1994; 31:467-73.
32. Oranje AP, Bruynzeel DP, Stenveld HJ, et al. Immediate-and delayed-type contact hypersensitivity in children older than 5 years with atopic dermatitis: a pilot study comparing different tests. Pediatr Dermatol 1994;11:209-15.
33. Lewis FM, Shah M, Gawkrodger DJ. Contact sensitivity in atopic dermatitis. Am J Contact Dermatitis 1995;6: 150-2.
34. Rothe MJ. The dust mite and atopic dermatits. Fitzpatrick's J Clin Dermatol 1995;3:29-32.
35. Mathews KP. Other inhalant allergens. In: Middleton E Jr, Reed CE, Ellis EF, et al, editors. Allergy: principles and practice. St Louis: Mosby, 1988:358-72.
36. Platts-Mills TAE, de Weck AL. Dust mite allergens and asthma - a worldwide problem. J Allergy Clin Immunol 1985;83:416-27.
37. Warner JA. Creating optimal conditions for the house dust mite. Clin Exp Allergy 1994;24:207-9.
38. Platts-Mills TAE, Ward GW, Sporik R, et al. Epidemiology of the relationship between exposure to indoor allergens and asthma. Int Arch Allergy Appl Immunol 1991; 94:339-45.
39. Colloff MJ. Exposure to house dust mites in homes of people with atopic dermatitis. Br J Dermatol 192;127: 322-7.
40. Adinoff AD, Tellez P, Clark RAD. Atopic dermatitis and aeroallergen contact sensitivity. J Allergy Clin Immunol 1988;81:736-42.
41. Platts-Mills TAE, Mitchell EB, Rowntree S, et al. The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol 1983;8:233-47.
42. Saint-Remy J-MR, Machiels JJ. Allergen-antibody complexes in the treatment of Dermatophagoides pteronyssinus hypersensitivity diseases. Clin Exp Allergy 1994; 24:1091-3.
43. Seidenari S, Manzini BM, Danese P, et al. Positive patch tests to whole mite culture and purified mite extracts in patients with atopic dermatitis, asthma, and rhinitis. Ann Allergy 1992;69:201-6.
44. Van Voorst Vader PC, Lier JG, Woest TE, et al. Patch tests with house dust mite antigens in atopic dermatitis patients. Acta Derm Venereol (Stockh) 1991;71: 301-5.
45. Castelain M, Birnbaum J, Casterlain P-Y, et al. Patch test reactions to mite antigens: a GERDA multicentre study. Contact Dermatitis 1993;29:246-50.
46. Imayama S, Hashizume T, Miyahara H, et al. Combination of patch test and IgE for dust mite antigens differentiates 130 patients with atopic dermatitis into four groups. J Am Acad Dermatol 1992;27:531-8.
47. Apter AJ, Rothe MJ, Grant-Kels JM. Allergy consultation in the management of atopic dermatitis. Pediatr Dermatol 1991;8:341-7.
48. Hide DW, Matthews S, Matthews L, et al. Effect of allergen avoidance in infancy on allergic manifestations at age two years. J Allergy Clin Immunol 1994;93:842-6.
49. Sigurs N, Hattevig G, Kjellman B. Maternal avoidance of eggs, cow's milk, and fish during lactation: effect on allergic manifestations, skin-prick tests, and specific IgE antibodies in children at age 4 years. Pediatrics 1992; 89:735-9.
50. Falth-Magnusson K, Kjellman NI. Allergy prevention by maternal elimination diet during late pregnancy - a 5-year follow-up of a randomized study. J Allergy Clin Immunol 1992;89:709-13.
51. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995;95:1179-90.
52. Guillet G, Guillet M-H. Natural history of sensitizations in atopic dermatitis: a 3-year follow-up in 250 children. Arch Dermatol 1992;128:187-92.
53. Young E, Stoneham MD, Petruckevitch A, et al. A population study of food intolerance. Lancet 1994;343:1127-30.
54. Niestijl Jansen JJ, Kardinaal AFM, Huijbers G, et al. Prevalence of food allergy and intolerance in the adult Dutch population. J Allergy Clin Immunol 1994;93:446-56.
55. Oranje AP, Aarsen RSR, Mulder PGH, et al. Food immediate-contact hypersensitivity (FICH) and elimination diet in young children with atopic dermatitis: preliminary results in 107 children. Acta Derm Venereol Suppl (Stockh) 1992;176:41-4.
56. Janssens V, Morren M, Dooms-Goossens A, et al. Protein contact dermatitis: Myth or reality? Br J Dermatol 1995; 132:1-6.
57. Skov L, Baadsgaard O. Superantigens: Do they have a role in skin diseases? Arch Dermatol 1995;131: 829-32.
58. Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994;56:36-40.
59. Halbert AR, Weston WL, Morelli SG. Atopic dermatitis: Is it an allergic disease? J Am Acad Dermatol 1995; 33:1008-18.
60. Hide DW, Arshad SH, Twiselton R, et al. Cord serum IgE: an insensitive method for prediction of atopy. Clin Exp Allergy 1991;21:739-43.
61. Ruiz RGG, Richards D, Kemeny DM, et al. Neonatal IgE: a poor screen for atopic disease. Clin Exp Allergy 1991; 21:467-72.
62. Vassella CC, Odelram H, Kjellman N-IM, et al. High anti-IgE levels at birth are associated with a reduced allergy prevalence in infants at risk: a prospective study. Clin Exp Allergy 1994;24:771-7.
63. Borres MP, Odelram H, Irander K, et al. Peripheral blood eosinophilia in infants at 3 months of age is associated with subsequent development of atopic disease in early childhood. J Allergy Clin Immunol 1995;95:694-8.
64. Sigurs N, Hattevig G, Kjellman B, et al. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol 1994;94:757-63.
65. Bos JD, Wierenga EA, Sillevis Smitt JH, et al. Immune dysregulation in atopic eczema. Arch Dermatol 1992; 128:1509-12.
66. Pene J, Rousset F, Briere F, et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons δ and α and prostaglandin E2. Proc Natl Acad Sci U S A 1988;85:6880-4.
67. Tang MLK, Kemp AS, Thorburn J, et al. Reduced interferon-γ secretion in neonates and subsequent atopy. Lancet 1994;344:983-5.
68. Warner JA, Miles EA, Jones AC, et al. Is deficiency of interferon gamma production by allergen-triggered cord blood cells a predictor of atopic eczema? Clin Exp Allergy 1994;24:423-30.
69. Galli E, Picardo M, Chini L, et al. Analysis of polyunsaturated fatty acids in newborn sera: A screening tool for atopic disease? Br J Dermatol 1994;130:752-6.
70. Kapp A, Czech W, Krutmann J, et al. Eosinophil cationic protein in sera of patients with atopic dermatitis. J Am Acad Dermatol 1991;24:555-8.
71. Czech W, Krutmann J, Schopf E, et al. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 1992; 126:351-5.
72. Kagi MK, Joller-Jemelka H, Wuthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992;185:88-92.
73. Huang S-W, Kao K-J. The relationship between plasma thrombospondin level and the clinical course of atopic dermatitis. Allergy Proc 1993;14:357-61.
74. Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 1993;129:422-30.
75. van Joost Th, Heule F, Korstanje M, et al. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994;130:634-40.
76. Granlund H, Erkko P, Sinisalo M, et al. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy. Br J Dermatol 1995;132:106-12.
77. Sepp N, Fritsch PO. Can Cyclosporin A induce permanent remission of atopic dermatitis? Br J Dermatol 1993; 128:213-6.
78. Korstanje MJ, van de Staak WJ. Cyclosporin maintenance therapy for severe atopic dermatitis. Acta Derm Venereol (Stockh) 1991;71:356-7.
79. Munro CS, Levell NJ, Shuster S, et al. Maintenance treatment with Cyclosporin in atopic eczema. Br J Dermatol 1994;130:376-80.
80. Camp RDR, Reitamo S, Friedmann PS, et al. Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993. Br J Dermatol 1993;129:217-20.
81. Hanifin JM, Schneider LC, Leung DYM, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189-97.
82. Reinhold U, Kukel S, Brzoska J, et al. Systemic interferon gamma treatment in severe atopic dermatitis. J Am Acad Dermatol 1993;29:58-63.
83. Nishioka K, Matsunaga T, Katayama I. Gamma-interferon therapy for severe cases of atopic dermatitis of the adult type. J Dermatol 1995;22:181-5.
84. Horneff G, Dirksen U, Wahn V. Interferon-gamma for treatment of severe atopic eczema in two children. Clin Invest 1994;72:400-3.
85. Souillet G, Rousset F, Devries JE. Alpha-interferon treatment of patient with hyper IgE syndrome [letter]. Lancet 1989; 1:1384.
86. MacKie RM. Interferon alpha for atopic dermatitis. Lancet 1990;335:1282-3.
87. Jullien D, Nicolas JF, Frappaz A, et al. Alpha interferon treatment in atopic dermatitis. Acta Derm Venereol (Stockh) 1993;73:130-2.
88. Pung Y-H, Vetro SW, Bellanti JA. Use of interferons in atopic (IgE-mediated) diseases. Ann Allergy 1993; 71:234-8.
89. Harper JJ, Mason UA, White TR, et al. A double-blind placebo-controlled study of thymostimulin (TP-1) for the treatment of atopic eczema. Br J Dermatol 1991;125:368-72.
90. Hsieh K-H, Shaio M-F, Liao T-N. Thymopentin treatment in severe atopic dermatitis - clinical and immunological evaluations. Arch Dis Child 1992;67:1095-102.
91. Stiller MJ, Shupack JL, Kenny C, et al. A double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis. J Am Acad Dermatol 1994;30: 597-602.
92. Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992;27:29-34.
93. Stadler JF, Fleury M, Sourisse M, et al. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol 1994;131:536-40.
94. Thestrup-Pedersen K. Topical steroids and growth in children with atopic dermatitis. Fitzpatrick's J Clin Dermatol 1995;3:44-6.
95. Broberg A, Faergemann J. Topical antimycotic treatment of atopic dermatitis in the head/neck area: a double-blind randomised study. Acta Derm Venereol (Stockh) 1995; 75:46-9.
96. La Rosa M, Ranno C, Musarra I, et al. Double-blind study of cetirizine in atopic eczema in children. Ann Allergy 1994;73:117-22.
97. Drake LA, Fallon JD, Sober A, et al. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. J Am Acad Dermatol 1994;31:613-6.
98. Veien NK, Kaaber K, Larsen PØ, et al. Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial. J Am Acad Dermatol 1995;32:1056-7.
99. Kimata H, Hiratsuka S. Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodium cromoglycate solution with the oral anti-allergic medication oxatomide. Eur J Pediatr 1994;153:66-71.
100. Jekler J, Larko O. UVA solarium versus UVB phototherapy of atopic dermatitis: a paired-comparison study. Br J Dermatol 1991;125:569-72.
101. George SA, Bilsland DJ, Johnson BE, et al. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severeadultatopicdermatitis. BrJDermatol1993;12:49-56.
102. Krutmann J, Czech W, Diepgen T, et al. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992;26:225-30.
103. Kowalzick L, Kleinheinz A, Weichenthal M, et al. Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol (Stockh) 1995; 75:43-5.
104. Sheehan MP, Atherton DJ, Norris P, et al. Oral psoralen photochemotherapy in severe childhood atopic eczema: an update. Br J Dermatol 1993;129:431-6.
105. Ogawa H, Yoshiike T. Atopic dermatitis: Studies of skin permeability and effectiveness of topical PUVA treatment Pediatr Dermatol 1992;4:383-5.
106. Nakagawa H, Etoh T, Ishibashi Y, et al. Tacrolimus ointment for atopic dermatitis [letter]. Lancet 1994;344:883.
107. Aoyama H, Tabata N, Tanaka M, et al. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. Br J Dermatol 1995;133:494-6.
108. Koblenzer CS. Psychotherapy for intractable inflammatory dermatoses. J Am Acad Dermatol 1995;32:609-12.
109. Stewart AC, Thomas SE. Hypnotherapy as a treatment for atopic dermatitis in adults and children. Br J Dermatol 1995;132:778-83.
110. Sheehan MP, Atherton DJ. One-year follow up of children treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 1994;130:488-93.
111. Sheehan MP, Stevens H, Ostlere LS, et al. Follow-up of adult patients with atopic eczema treated with Chinese herbal therapy for 1 year. Clin Exp Dermatol 1995;20:136-40.
112. Leroy BP, Boden G, Lachapelle J-M, et al. A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study. J Am Acad Dermatol 1993;28:232-9.
113. Leroy BP, Jacquemin MG, Lachapelle JM, et al. Allergen-sensitive atopic dermatitis is improved by injections of allergen combined with F(ab')2 fragments of specific antibodies. Br J Dermatol 1995;132:599-603.
114. Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992; 22:440-6.
115. Kort HSM, Koers WJ, van Nes AMT, et al. Clinical improvement after unusual avoidance measures in the home of an atopic dermatitis patient. Allergy 1993;48:468-71.
116. Soyland E, Funk J, Rajka G, et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis: a double-blind, multicentre study. Br J Dermatol 1994;130:757-64.
117. Fiocci A, Sala M, Signoroni P, et al. The efficacy and safety of gamma-linolenic acid in the treatment of infantile atopic dermatitis. J Int Med Res 1994;22:24-32.
118. Berth-Jones J, Graham-Brown R. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993;341:1557-60.
119. Mabin DC, Sykes AE, David TJ. Controlled trial of a few foods diet in severe atopic dermatitis. Arch Dis Child 1995;73:202-7.
120. Magnarin M, Knowles A, Ventura A, et al. A role for eosinophils in the pathogenesis of skin lesions in patients with food-sensitive atopic dermatitis. J Allergy Clin Immunol 1995;96:200-8.
121. Linna O, Kokkonen J, Lahtela P, et al. Ten-year prognosis for generalized infantile eczema. Acta Paediatrica 1992;81:1013-6.
122. Kissling S, Wuthrich B. Dermatitis in young adults: personal follow-up 20 years after diagnosis in childhood. Hautarzt 1994;45:368-71.
123. Lammintausta K, Kalimo K, Raitala AR, et al. Prognosis of atopic dermatitis: a prospective study in early adult-hood. Int J Dermatol 1991;30:563-8.